Oscar Health (NYSE:OSCR) Shares Down 4.2% – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR) shares traded down 4.2% on Wednesday . The stock traded as low as $14.25 and last traded at $14.03. 487,889 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 3,575,779 shares. The stock had previously closed at $14.65.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective for the company. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $21.56.

Oscar Health Stock Down 4.9 %

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a 50 day simple moving average of $15.23 and a 200-day simple moving average of $16.47. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of -693.35 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of OSCR. Vanguard Group Inc. increased its stake in shares of Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock valued at $255,333,000 after buying an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C increased its stake in shares of Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after buying an additional 3,983,325 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after buying an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC increased its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC increased its stake in shares of Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after buying an additional 2,151,256 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.